Addus HomeCare Heads Into Q3 Print With Bulls and Bears Split

ADUS reports Q3 results on November 4 with the stock up 14% in the past month and options traders showing no particular anxiety about the outcome.

The lending market tells a relaxed story. Availability is exceptionally loose at 971%, meaning roughly ten shares are available to borrow for every one already shorted. Borrowing costs are negligible at 0.43%. Short interest of 4.7% of the free float has actually declined about 8% over the past month, even as the stock rallied to $126.55. The put/call ratio at 0.15 is barely above its 20-day average of 0.15, a z-score of just 0.14, leaving options positioning effectively neutral. None of these signals suggest meaningful conviction on either side of the trade into the print.

The sharpest disagreement is between analysts. B of A Securities downgraded to Neutral in September, cutting its target to $125, essentially flat to where the stock trades today. That move followed a pattern of target reductions from Barclays, which has maintained an Underweight with a $96 target, well below the current price. Against that, RBC Capital raised its Outperform target to $134 after the last print, and Citizens has held a Market Outperform at $142. The mean analyst target of $134 implies modest upside from current levels, but the spread from $96 to $142 reflects a genuine disagreement about execution risk. The bull case rests on the personal care franchise, where same-store revenue grew 6.5% and adjusted EBITDA margins came in at 12.2% in Q1, alongside a clean balance sheet with $103 million in cash and meaningful free cash flow generation. Bears focus on concentration risk: more than 20% of revenue runs through Illinois's Community Care Program, and the hospice segment missed expectations last quarter with home health visits down 15% year-on-year. Policy and reimbursement risk from the Medicaid Access Rule sits in the background.

Retail attention has spiked sharply relative to the company's own history. ORTEX's Wikipedia and stock-page view signal registered a z-score of 6.1 as of October 19, far above normal levels. This dataset tracks attention, not revenue, but the surge coincides with the stock's strong monthly run and may reflect growing awareness of the name ahead of the report.

BlackRock has built a substantial 18.7% institutional stake, the largest on the register, adding 335,000 shares in the most recent reporting period. American Century added 246,000 shares as of August. The base of institutional ownership looks supportive rather than speculative. The stock's two most recent earnings reactions were muted: a 0.5% decline on the day last October and a 0.3% fall in August, with both recovering to small gains over the following five sessions.

The print will test whether the hospice and home health segments are stabilising after last quarter's stumble, and whether the personal care business can sustain its growth rate at margins that justify a stock now trading near the top of its analyst target range.